Article
Transcriptional Blood Signatures for Active and Amphotericin B Treated Visceral Leishmaniasis in India
2019-02-18
Abstract excerpt
Amphotericin B provides improved therapy for visceral leishmaniasis (VL) caused by Leishmania donovani , with single dose liposomal-encapsulated Ambisome providing the best cure rates. The VL elimination program aims to reduce the incidence rate in the Indian subcontinent to <1/10,000 population/year. Ability to predict which asymptomatic individuals (e.g. anti-leishmanial IgG and/or Leishmania-specific modified...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5e4bb89d-e24b-54c5-b302-4216da47d836
- DOI
- 10.1101/554022
